Versant Ventures VI GP, L.P., 10% Owner at Monte Rosa Therapeutics, Inc. (GLUE), sold 576,482 shares at $6.00 ($3.5M) on 2024-09-11, disclosed to the SEC on 2024-09-13.
Open-market sale of $3.5M GLUE by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.00 | 541,897 | $3.3M | 93.9% |
| 2 | $6.00 | 16,047 | $96K | 2.8% |
| 3 | $6.16 | 9,269 | $57K | 1.6% |
| 4 | $6.16 | 9,269 | $57K | 1.6% |
| Total | $6.01 avg | 576,482 | $3.5M | 100% |
| Filing → |
| AKRO | SELL | 2020-07-10 | $2.1M | — | Filing → |
| PASG | BUY | 2020-03-03 | $4.0M | — | Filing → |